Both ZHX2 and ZHX3 expressions were remarkably reduced in TNBC tissues, and a high mRNA expression of ZHX2 and ZHX3 were closely associated with a better prognosis of breast cancer patients, especially in luminal A subtype breast cancer. Here, ZHX2 is linked to breast carcinoma.